SHEFFIELD

Enbridge Publishes 23rd Annual Sustainability Report

Retrieved on: 
Friday, May 10, 2024
GHG, Indigenous peoples, Task force, Methane, Oil, Report, AB, Sustainability accounting, Workforce, Distributor, Carbon accounting, Safety, Person, ENB, TCFD, Eye, Woman, Disability, Environment, GRI, TSX, Renewable energy

Company outlines progress across environment, social and governance priorities

Key Points: 
  • Company outlines progress across environment, social and governance priorities
    CALGARY, AB, May 10, 2024 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today published its 2023 Sustainability Report.
  • "Across Enbridge, our employees are advancing a sustainable business strategy," said Pete Sheffield, Enbridge Vice President and Chief Sustainability Officer.
  • "In our 23rd Sustainability Report, we update stakeholders on our progress against the sustainability goals we set in 2020 and the work remaining.
  • Click to read the full Enbridge 2023 Sustainability Report and the 2023 ESG Datasheet , including the TCFD.

Burlwood Wealth Launches With Support From LPL Strategic Wealth Services

Retrieved on: 
Monday, May 6, 2024
CFO, Small business, SW, Business development, Entrepreneurship, UBS, Emotion, Freedom, Retirement, Culture, DNA, Silicon, LPL, Physician, Wood, SAN, Financial adviser

SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Matt Sheffield has launched a new independent practice, Burlwood Wealth , through affiliation with LPL Financial’s supported independence model, LPL Strategic Wealth Services .

Key Points: 
  • SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Matt Sheffield has launched a new independent practice, Burlwood Wealth , through affiliation with LPL Financial’s supported independence model, LPL Strategic Wealth Services .
  • He reported having served approximately $275 million in advisory, brokerage and retirement plan assets* and joins LPL from UBS.
  • I’m looking forward to continuing the processes that have made my practice successful, while also delivering more seamless, personalized experiences.”
    In going independent, Sheffield turned to LPL Strategic Wealth Services (SW), which combines the freedom and flexibility of entrepreneurship with hands-on business services and support to help practices thrive, both operationally and strategically.
  • We look forward to a long-lasting relationship with Burlwood Wealth.”

Falcon Oil & Gas Ltd - Results of Fundraising

Retrieved on: 
Monday, April 22, 2024
ACT, RESPECT, THIS, FOG, Daly Waters, Fundraising, AIM, FCA, ANY, WERE, Beetaloo, Book building, TSX Venture Exchange, WITH, AS, EUROPEAN UNION, Indian stock exchange, VIA, Subscription business model, Cryptocurrency

Falcon Oil & Gas Ltd (AIM: FOG, TSXV: FO.V), the international oil and gas company engaged in the exploration and development of unconventional oil and gas assets, is pleased to confirm the results of the proposed Fundraising announced by the Company on 18 April 2024.

Key Points: 
  • Falcon Oil & Gas Ltd (AIM: FOG, TSXV: FO.V), the international oil and gas company engaged in the exploration and development of unconventional oil and gas assets, is pleased to confirm the results of the proposed Fundraising announced by the Company on 18 April 2024.
  • As previously announced, alongside the Fundraising, Falcon Oil & Gas Australia Limited (“Falcon Australia”) has agreed to grant Daly Waters Energy, LP (“Daly Waters”) and a major US-based energy industry service provider overriding royalty interests (“ORRIs”) over Falcon Australia’s working interests in the Beetaloo Sub-Basin exploration permits in return for cash payments of US$3 million and US$1 million, respectively.
  • Thomas Layman, a Director of the Company, participated in the Fundraising.
  • The number of New Common Shares conditionally subscribed for by him pursuant to the Subscription, and his resulting shareholding on First Admission, is set out below:

MINORITY SHAREHOLDERS OF WADL TO RALLY IN RESPONSE TO FCC LICENSE TRANSFER DELAY

Retrieved on: 
Monday, April 15, 2024
FCC, Democracy, WADL, Muslims

SOUTHFIELD, Mich., April 15, 2024 /PRNewswire/ -- WADL minority shareholder Horace Sheffield alongside 14% shareholders expressed profound disappointment with the decision led by Biden appointee FCC Chairwoman Jessica Rosenworcel to delay the station's license transfer.

Key Points: 
  • SOUTHFIELD, Mich., April 15, 2024 /PRNewswire/ -- WADL minority shareholder Horace Sheffield alongside 14% shareholders expressed profound disappointment with the decision led by Biden appointee FCC Chairwoman Jessica Rosenworcel to delay the station's license transfer.
  • The Sheffield family, which has held a minority stake in WADL for over three decades, views this delay as a continuation of the FCC's historic shortcomings in promoting diversity and accountability.
  • The planned demonstrations reflect a wider call for the FCC to advance its commitment to a diverse and inclusive media landscape.
  • For further information and rally details, please contact: Andre Ash (313) 293- 2931.

One Heritage Group plc: Practical Completion of North Church House, Sheffield

Retrieved on: 
Wednesday, March 13, 2024
Completion, SSH, Construction

Practical Completion of North Church House, Sheffield

Key Points: 
  • Practical Completion of North Church House, Sheffield
    One Heritage Group PLC (LSE: OHG), the UK-based residential developer focused on the North of England, is pleased to announce the practical completion of North Church House, Sheffield, a residential redevelopment comprising 58 one and two bed apartments of a seven storey former office building in Sheffield City Centre.
  • This takes effect following the completion of North Church House.
  • “We are pleased to announce the completion of North Church House, Sheffield marking our second successful development management project.
  • With this project’s conclusion, we are also implementing a strategic shift by ceasing in-house construction for both direct development and development management projects.

HeyTutor Approved To Deliver High-Impact, In-Person Tutoring to Michigan School Districts

Retrieved on: 
Monday, February 12, 2024
Technology, Health, Entertainment, Online, Public Policy, Government, Training, Preschool, Other Education, Continuing, Primary, Secondary, Education, Internet, COVID-19, Other Policy Issues, MAISA, Student, Tutoring

HeyTutor, one of the largest in-person tutoring companies in the United States, announces its selection as an approved provider of in-person, high-impact tutoring services by the Michigan Association of Intermediate School Advisors (MAISA) for school districts pursuing grant funding through the “MI Kids Back on Track” program.

Key Points: 
  • HeyTutor, one of the largest in-person tutoring companies in the United States, announces its selection as an approved provider of in-person, high-impact tutoring services by the Michigan Association of Intermediate School Advisors (MAISA) for school districts pursuing grant funding through the “MI Kids Back on Track” program.
  • HeyTutor, founded in 2014, currently serves thousands of students in states including Arizona, California, Connecticut, Florida, Hawaii, New Jersey, New Hampshire, Maine, Missouri, Texas, Washington, and Wisconsin.
  • “Pandemic-induced learning loss continues to impact student achievement and test scores across the country, and states like Michigan are embracing high-dosage tutoring as an effective and necessary intervention to get students back on track,” said HeyTutor CEO Jennifer Sheffield.
  • “We applaud Governor Whitmer’s commitment to investing in Michigan’s youth and look forward to offering HeyTutor’s research-backed, customized, and effective in-person tutoring platform to school districts across the state.”
    The Education Trust Midwest’s State of Michigan Education Department report echoed the governor’s pleas to help low-income students who suffered academic setbacks during the pandemic.

The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack

Retrieved on: 
Wednesday, February 7, 2024
Partnership, BHP, Hospital, Trial of the century, STEMI, Heart, Clinical trial, Percutaneous coronary intervention, Patient, Safety, Splenic infarction, Queen Elizabeth Hospital, University, Northern General Hospital, University of Birmingham, Myocardial infarction, Stroke, Associate, Pharmaceutical industry

February 7, 2024, the University of Birmingham and Acticor Biotech are proud to announce the first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.

Key Points: 
  • February 7, 2024, the University of Birmingham and Acticor Biotech are proud to announce the first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.
  • In 2022, the University of Birmingham and Acticor Biotech signed a partnership agreement to evaluate glenzocimab efficacy in myocardial infarction in a new clinical trial called LIBERATE.
  • This study is exploring the potential of glenzocimab in reducing the type of blood clotting responsible for heart damage during heart attacks.
  • Birmingham Health Partners is a strategic alliance between five organisations who collaborate to bring healthcare innovations through to clinical application:

FDA Grants Breakthrough Device Designation to ORTHOSON's Bio-Structural Gel

Retrieved on: 
Wednesday, February 7, 2024
Biotechnology, FDA, Pharmaceutical, Health, Breakthrough, Intervertebral disc, Patient, I Am the Moon, Food, Degenerative disc disease, Back pain, Biomedical engineering, University, Doctor of Philosophy, Sheffield Hallam University, Medical device

ORTHOSON , a medtech innovator developing a portfolio of novel treatments for back pain, today announced that its Bio-Structural Gel product has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • ORTHOSON , a medtech innovator developing a portfolio of novel treatments for back pain, today announced that its Bio-Structural Gel product has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • ORTHOSON's Bio-Structural Gel follows the natural fissures of degeneration in the nucleus pulposus of the intervertebral disc, before gelling in-situ to form a highly-hydrated biology-supporting structure.
  • “Gaining Breakthrough Device Designation is a significant achievement that will prioritize our work with the FDA as we go through the regulatory process,” said Ken Reali, chair of ORTHOSON.
  • “We believe the Breakthrough Device Designation for our Bio-Structural Gel is a testament to our team's spirit of innovation and dedication.

EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO

Retrieved on: 
Thursday, February 1, 2024
Bachelor of Science, Growth, CFO, Therapy, Patient, KPMG, Vertex Pharmaceuticals, Regulatory affairs, Biomedical sciences, Urinary tract infection, Physics, University of Nottingham, University, Doctor of Philosophy, Senior, Clinical research

Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.

Key Points: 
  • Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.
  • He joins the Company from BerGenBio, a biotech company developing innovative drugs for oncology and serious respiratory infections, where he was COO.
  • Dr Barnes previously worked at Vertex Pharmaceuticals as Director of Regulatory Affairs where he led the strategy development of several breakthrough products.
  • With our first clinical data expected this year, the newly strengthened Executive Team will support the development and growth of our business.